| Factor Information | |
|---|---|
| Data ID | 1523 |
| Factor | GDF-15 |
| Description | Correlations between GDF-19 and other biomarkers. |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | diagnosis and prognosis |
| Objective | Correlations between GDF-15 and other biomarkers in CHD |
| p Value | <0.001 |
| HR | 3.5 |
| Conclusion | Elevated GDF-15 was associated with NYHA class II and III. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 537 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
| Reference | |
|---|---|
| PMID | 26402453 |
| Year | 2016 |
| Title | Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | blood | |
| Region | Netherlands,Rotterdam | |
| Method | Multivariate logisitic regression analysis | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | ACHD(Treatment) | ACHD(Control) |
| Number | 587(ACHD) | 587(ACHD) |
| Age | 33 years(25-41) | 33 years(25-41) |
| Gender (Male: Female) | 344:243 | 344:243 |
| Marker Level | N/A | N/A |
